Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 14, 2021 - The FDA approved UCB’s Vimpat (lacosamide), for the treatment of partial-onset seizures in patients 1 month of age and older.
Return to publications